Consensus panel guidelines for the use of intrathecal baclofen therapy in poststroke spastic hypertonia
| Autor: | Stuart A. Yablon, Laura Wiggs, Samuel Grissom, Mya C. Schiess, Steven Cavalier, Gerard E. Francisco |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
medicine.medical_specialty
Baclofen Exacerbation Population MEDLINE chemistry.chemical_compound Physical medicine and rehabilitation Spastic Medicine Humans Spasticity education Stroke Injections Spinal Community and Home Care education.field_of_study business.industry Muscle Relaxants Central Rehabilitation medicine.disease chemistry Muscle Spasticity Practice Guidelines as Topic Physical therapy Hypertonia Neurology (clinical) medicine.symptom business |
| Zdroj: | Topics in stroke rehabilitation. 13(4) |
| ISSN: | 1074-9357 |
| Popis: | Intrathecal baclofen (ITB) therapy has been increasingly employed for the management of poststroke spastic hypertonia, a complication that can lead to deformity, discomfort, and exacerbation of motor impairments. Because its use in stroke is not as established as other indications, ITB therapy has not been subjected to rigorous investigation. There is limited evidence to guide clinicians regarding application of this therapy in this patient population. This article aims to review the available scientific literature and the opinion of several experts on the topic. It will also describe the recommendations of these experts with regard to addressing common clinical situations that may influence treatment decisions in the stroke population. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|